Human T cell leukemia virus type I and Epstein-Barr virus antibodies in homosexuals and hemophilia patients from Venezuela. NLM AIDSLINE Important note: Information in this article was accurate in 1986. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Human T cell leukemia virus type I and Epstein-Barr virus antibodies in homosexuals and hemophilia patients from Venezuela.

AIDS Res. 1984-85;1(6):395-400. Unique Identifier : AIDSLINE MED/86242470
Merino F; DeSalvo L; Medina JW

Abstract: The presence of serum antibodies to human T-cell leukemia/lymphoma Virus-I (HTLV-I) and to Epstein-Barr Virus (EBV) was studied in homosexuals and hemophilia patients from the State of Zulia (Venezuela), a highly endemic area for HTLV-I infection. No serum antibodies to HTLV-I were detected despite the presence of alterations in peripheral blood lymphocyte subsets. Anti-EBV antibodies in homosexuals were indicative of persistent infection with this virus. Our results suggest that HTLV-I does not play a role in the immunological alterations in homosexuals or hemophiliacs in an area of high prevalence for this virus.
Keywords: Antibodies, Monoclonal/DIAGNOSTIC USE Antibodies, Viral/*IMMUNOLOGY Comparative Study Cross-Sectional Studies Hemophilia/*IMMUNOLOGY Herpesvirus 4, Human/*IMMUNOLOGY *Homosexuality Human HTLV-BLV Viruses/*IMMUNOLOGY Male T-Lymphocytes, Cytotoxic/CYTOLOGY T-Lymphocytes, Helper-Inducer/CYTOLOGY Venezuela JOURNAL ARTICLE

KWDantibodies,monoclonal/diagnosticuseantibodies,viral/KWDimmunologycomparativestudycross-sectionalstudieshemophilia/KWDimmunologyherpesvirus4,human/KWDimmunologyKWDhomosexualityhumanhtlv-blvviruses/KWDimmunologymalet-lymphocytes,cytotoxic/cytologyt-lymphocytes,helper-inducer/cytologyvenezuelajournalarticle
861030
M86A0290

Copyright © 1986 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1986. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1986. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .